Detalhe da pesquisa
1.
Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates.
Int J Mol Sci
; 23(20)2022 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36293515
2.
Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas.
Int J Mol Sci
; 23(22)2022 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36430263
3.
Novel Tyrosine Kinase Targets in Urothelial Carcinoma.
Int J Mol Sci
; 22(2)2021 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33451055
4.
Tyrosine Kinase Receptors in Oncology.
Int J Mol Sci
; 21(22)2020 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33198314
5.
Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to Therapy.
Int J Mol Sci
; 21(14)2020 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668761
6.
Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance Mechanisms.
Int J Mol Sci
; 20(19)2019 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31597249
7.
Adoptive T cell therapy for solid tumors: current landscape and future challenges.
Front Immunol
; 15: 1352805, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38550594
8.
Current Landscape of Immunotherapy for Advanced Sarcoma.
Cancers (Basel)
; 15(8)2023 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190214
9.
Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature.
Front Oncol
; 13: 1158981, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37213307
10.
Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma.
Cancers (Basel)
; 15(3)2023 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765821
11.
Novel therapeutic approaches in GEP-NETs based on genetic and epigenetic alterations.
Biochim Biophys Acta Rev Cancer
; 1877(5): 188804, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152904
12.
Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?
Cancers (Basel)
; 14(24)2022 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36551557
13.
Epigenetics in advanced renal cell carcinoma: Potential new targets.
Crit Rev Oncol Hematol
; 180: 103857, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36257538
14.
Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report.
Transl Lung Cancer Res
; 11(7): 1497-1502, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35958343
15.
Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies.
Cancer Treat Rev
; 105: 102372, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35248904
16.
Management of Intracranial Metastases in EGFR-Mutated NSCLC: A Review of Literature following an Unusual Case Report.
Case Rep Oncol Med
; 2021: 5526809, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34306781
17.
Acute anti-Ma2 paraneoplastic encephalitis associated to pembrolizumab: a case report and review of literature.
Transl Lung Cancer Res
; 10(7): 3303-3311, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34430366
18.
Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell Carcinoma.
Cancers (Basel)
; 13(23)2021 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34885091
19.
BRAF Mutated Colorectal Cancer: New Treatment Approaches.
Cancers (Basel)
; 12(6)2020 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32545884